Displaying 2 results
ESG risks facing biopharmaceutical firms
Pricing, product governance and legal liabilities are some of the factors to consider when assessing drug companies.
Covid-themed ETF shifts focus to monkeypox
As the White House declares monkeypox a national health emergency, ETFMG tweaks its marketing without adjusting the portfolio.
